1
EXHIBIT 11.1
PARACELSUS HEALTHCARE CORPORATION
COMPUTATION OF EARNINGS PER SHARE
(In thousands, except per share data)
Three Months Ended Nine Months Ended
September 30, September 30,
------------------ -----------------
1996 1995 1996 1995
------- ------- ------ ------
Primary:
- -------
(1) Net income (loss) $(80,123) $ 3,323 $(86,864) $10,505
-------- ------- -------- -------
Shares used in this computation:
Weighted average common
shares outstanding 42,290 29,772 33,975 29,772
Shares applicable to stock
options and warrants, net
of shares assumed to be
purchased from proceeds at
average market price (a) - (a) -
-------- ------- -------- -------
(2) Total shares for net income
per share computation 42,290 29,772 33,975 29,772
======== ======= ======== =======
Income (loss) per share:
Continuing operations $ (1.19) $ 0.12 $ (1.34) $ 0.31
Discontinued operations (0.60) (0.01) (1.08) 0.04
Extraordinary loss (0.10) - (0.14) -
-------- ------- -------- -------
Net Income (loss) per share
(1 divided by 2) $ (1.89) $ 0.11 $ (2.56) $ 0.35
======== ======= ======== =======
Fully Diluted:
- -------------
(3) Net income (loss) (1) $(80,123) $ 3,323 $(86,864) $10,505
======== ======= ======== =======
Shares used in this computation:
Total primary shares (2) 42,290 29,772 33,975 29,772
Shares applicable to stock
options and warrants in
addition to those used in
primary computation due to
the use of period-end
marker price when higher
than average (a) - (a) -
-------- ------- -------- -------
(4) Total fully diluted shares 42,290 29,772 33,975 29,772
======== ======= ======== =======
Income (loss) per share:
Continuing operations $ (1.19) $ 0.12 $ (1.34) $ 0.31
Discontinued operations (0.60) (0.01) (1.08) 0.04
Extraordinary loss (0.10) - (0.14) -
-------- ------- -------- -------
Net Income (loss) per share
(3 divided by 4) $ (1.89) $ 0.11 $ (2.56) $ 0.35
======== ======= ======== =======
(a) The effect of options and warrants were anti-dilutive for the quarter and
nine months ended September 30, 1996.